Research Opportunity: High Cholesterol
Are you concerned with high cholesterol? Diablo Clinical Research is currently conducting a clinical research study for people with high cholesterol to better manage their cholesterol levels. Those who are currently on a daily dose of statin medication such as Lipitor, Crestor, Zocor, also known as Simvastatin, are invited to find out if they qualify [...]
Read Full Post | Make a Comment ( None so far )Research Opportunity: Cardiovascular Disease
Diablo Clinical Research is conducting a research study investigating the use of a medication to reduce your risk of future cardiovascular events (such as heart attack and stroke). You may qualify to participate if you have had at least one heart attack. Study participants may continue their current medication throughout the study. All study-related care [...]
Read Full Post | Make a Comment ( None so far )Clinical Research Study Opportunity
Do you have diabetes? Are you interested in a research study opportunity? Call Diablo Clinical Research today at (925) 930-7267 and ask for a recruiter. Related Articles Diabetes Study Opportunity! (diabloclinicalresearch.wordpress.com) Improve your Health… (diabloclinicalresearch.wordpress.com) The Diabetes Prevention Program: A Major Clinical Study (brighthub.com)
Read Full Post | Make a Comment ( None so far )Research Volunteer Opportunity!
Do you have diabetes? Are you interested in a research study opportunity? Call Diablo Clinical Research today at (925) 930-7267 and ask for a recruiter.
Read Full Post | Make a Comment ( None so far )Who is Diablo Clinical Research?
Diablo Clinical Research is an independent research organization located in Walnut Creek, CA. Our late-phase facility focuses on phase II, III, and IV clinical studies. It was established in 1995 and specializes in outpatient studies focusing on treatments for diabetes and its related complications including dyslipidemia, obesity, hypertension, neuropathy and metabolic syndrome as well as osteoporosis, fibromyalgia, arthritis and [...]
Read Full Post | Make a Comment ( None so far )
